• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

联合血液滤过与去铁胺治疗铝诱导的骨软化症。

Combined hemofiltration and desferrioxamine treatment for aluminum induced osteomalacia.

作者信息

Barré P E, Prichard S

出版信息

Int J Artif Organs. 1986 May;9(3):167-72.

PMID:3733242
Abstract

A 61-year-old male hemodialysis patient developed the syndrome of aluminum intoxication including bone pain, fractures, proximal myopathy, progressive anemia and expressive aphasia. Serum aluminum was 130 micrograms/l and rose to 445 micrograms/l after the administration of 2 grams of desferrioxamine. Bone biopsy of the iliac crest revealed severe osteomalacia, heavy staining for aluminum and a bone aluminum content of 229 mg/kg dry bone. Treatment with combined hemofiltration and desferrioxamine administration led to a marked clinical improvement and a repeat bone biopsy striking healing of the osteomalacia with a bone aluminum content of 11 mg/kg dry bone.

摘要

一名61岁的男性血液透析患者出现了铝中毒综合征,包括骨痛、骨折、近端肌病、进行性贫血和表达性失语。血清铝含量为130微克/升,在给予2克去铁胺后升至445微克/升。髂嵴骨活检显示严重骨软化、铝染色浓和骨铝含量为229毫克/千克干骨。联合血液滤过和给予去铁胺治疗导致临床显著改善,再次进行骨活检显示骨软化显著愈合,骨铝含量为11毫克/千克干骨。

相似文献

1
Combined hemofiltration and desferrioxamine treatment for aluminum induced osteomalacia.联合血液滤过与去铁胺治疗铝诱导的骨软化症。
Int J Artif Organs. 1986 May;9(3):167-72.
2
Do serum aluminum levels reflect underlying skeletal aluminum accumulation and bone histology before or after chelation by deferoxamine?血清铝水平能否反映去铁胺螯合治疗之前或之后潜在的骨骼铝蓄积情况及骨组织学状况?
J Lab Clin Med. 1985 Dec;106(6):674-81.
3
Aluminum-related osteomalacia: clinical and histological improvement following treatment with desferrioxamine (DFO).
Isr J Med Sci. 1987 Dec;23(12):1242-6.
4
[A case of iron and aluminum related osteomalacia in a long-term hemodialysis patient].[一名长期血液透析患者的铁和铝相关性骨软化症病例]
Nihon Jinzo Gakkai Shi. 1991 Apr;33(4):437-42.
5
[Desferrioxamine treatment of osteomalacia caused by aluminum poisoning].[去铁胺治疗铝中毒所致骨软化症]
Presse Med. 1986 Jan 18;15(2):55-9.
6
Improvement of anemia with deferoxamine in hemodialysis patients with aluminum-induced bone disease.去铁胺对铝诱导骨病血液透析患者贫血的改善作用
Clin Nephrol. 1985 Nov;24(5):237-41.
7
Successful treatment of dialysis osteomalacia and dementia, using desferrioxamine infusions and oral 1-alpha hydroxycholecalciferol.使用去铁胺输注和口服1-α羟胆钙化醇成功治疗透析性骨软化症和痴呆症。
Am J Nephrol. 1984;4(6):369-74. doi: 10.1159/000166855.
8
Treatment of dialysis osteomalacia with desferrioxamine.
Lancet. 1982 Aug 14;2(8294):343-5. doi: 10.1016/s0140-6736(82)90544-x.
9
Clearance of aluminum by hemodialysis: effect of desferrioxamine.血液透析对铝的清除:去铁胺的作用
Kidney Int Suppl. 1986 Feb;18:S100-3.
10
Fracture healing with deferoxamine therapy in a patient with aluminum-associated osteomalacia.去铁胺治疗铝相关性骨软化症患者的骨折愈合情况。
ASAIO Trans. 1986 Jul-Sep;32(1):198-200.